Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.
Status:
Unknown status
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
A phase 2 clinical trial to evaluate the the efficacy of different benznidazole regimens
(300mg/day for 60 days, 150mg/day for 60 days, and 400mg/day for 15 days) for the treatment
of chronic Chagas disease in adult patients. The efficacy is assessed through the proportion
of patients with negative parasitaemia measured by Polymerase Chain Reaction (PCR) during the
first 12 months after starting treatment. The study will be performed in Spain, Brazil,
Argentina and Colombia.
Phase:
Phase 2
Details
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute